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A report on the Cold Spring Harbor Laboratory meeting
‘Systems Biology: Global Regulation of Gene Expression’,
Cold Spring Harbor, USA, 27-30 March 2008.
The line between the biological and computational research
communities has disappeared in the field of gene regulation.
The group of regulatory biology researchers represented at
the recent meeting at Cold Spring Harbor on systems biology
shares the same goal: develop and apply experimental and
computational technologies to decipher the genomic regula-
tory code and the gene regulatory networks that are the
driving forces of development and evolution. As in previous
years, important gaps in solving the complex problem of
gene regulation were bridged. This year featured the emer-
ging massively parallel sequencing technologies, which are
now being applied to every conceivable step in the gene
regulation process, from gene annotation and alternative
splicing, to transcription factor binding, and chromatin
structure. Topics covered at the meeting ranged widely and
in this report, we give our impressions of some highlights in
two dominant themes: gene regulation in a nuclear context
and transcription factor binding specificity.
G Ge en no om me e   g ge eo og gr ra ap ph hy y   i in n   t th hr re ee e   d di im me en ns si io on ns s
When transcription factors are reading the genomic regulatory
code to determine the complement of active genes in a cell at a
given time, they can be aided, guided, or obstructed by the
chromatin they operate on. To catch chromatin in the
regulatory act, laboratories are sequencing the sites associated
with histone modifications that mark repressive, activating,
and bivalent chromatin states, high-resolution DNase I
hypersensitive sites (DHSs) that mark accessible chromatin,
possible insulator sites, sites bound by transcription factors
and RNA polymerase II, and in vivo cross-linked sites that
represent long-range regulatory interactions in a locus. In an
increasing number of laboratories, the regulatory geography
of the genome is now being assessed within the three-
dimensional context of the nucleus.
Bas van Steensel (Netherlands Cancer Institute, Amsterdam,
the Netherlands) provided an elegant picture of human gene
regulation in three dimensions by identifying nuclear-
lamina-associated domains (LADs) in interphase
chromosomes. LADs range from 100 kb to 10 Mb and have
sharp borders that define chromatin regions with distinctive
characteristics: they tend to have fewer genes with lower
expression levels compared with genes outside LADS, low
RNA polymerase II occupancy, and enrichment of the
repressive histone mark H3 trimethylated on lysine 27
(H3K27me3) at their borders. Thirty percent of LAD borders
have at least one of three other marks: binding sites for the
transcription factor CTCF (commonly held to act as insu-
lators), a CpG island, or a promoter directing transcription
away from the LAD.
Sites of chromatin accessibility across the human genome
were precisely delineated by John Stamatoyannopoulos
(University of Washington School of Medicine, St Louis,
USA) in nine cell types by ‘digital DNase I’, an in vivo assay
of DNase I hypersensitive sites identified by single-molecule
sequencing. Stamatoyannopoulos has identified around
400,000 DHSs genome-wide, of which around 170,000 were
highly regulated cell-type specific elements. A subset of
these are organized into approximately 2,000 tissue
‘regulons’, each comprising a large cluster of lineage-specific
elements spread out over tens or even hundreds of kilobases.
Genes that were marked by these regulons in a given cell
type showed striking over-representation of Gene Ontology
terms for processes associated with the cell lineage in which
they were observed. In addition to accessibility to DNase,
active enhancers show specific histone modifications. Gary
Hon (Ludwig Institute for Cancer Research, San Diego,
USA) was able to distinguish cell-type specific enhancersfrom promoters by their enrichment for H3K4me1 over
H3K4me3 modifications. He proposed that these enhancers
are what drive cell-type specific patterns of gene expression.
With such data it is critical to determine how different
regulon elements interact with each other to elicit a
response. Job Dekker (University of Massachusetts Medical
School, Worcester, USA) described his ‘chromosome
conformation capture carbon copy’ (5C) method to detect
many-by-many chromatin interactions for a picture of
spatial conformation of genomic regions. His analysis of a
1 Mb region around the human beta-globin locus showed
that an alternative promoter 250 kb upstream physically
interacts with the globin locus control region. Dekker
pointed out that “simple models are insufficient” for gene
regulation, as CTCF sites, usually considered as insulators,
at the beta-globin locus actually facilitate long-range
interactions between promoters and enhancers.
T Tr ra an ns sc cr ri ip pt ti io on n   f fa ac ct to or r   b bi in nd di in ng g   s sp pe ec ci if fi ic ci it ty y
We were reminded by Kevin Struhl (Harvard Medical
School, Boston, USA) that the epigenetic states of chromatin
cannot explain the specificity of gene expression, but are
rather instructed by the sequence-specific transcription
factors that translate the regulatory code and recruit
chromatin-modifying activities. A cornerstone of our under-
standing of the regulatory language is the knowledge of a
transcription factor’s DNA-binding specificity. Significant
progress has been achieved in deriving high-quality DNA-
binding profiles through a variety of approaches with a large
dose of collaboration, particularly with Martha Bulyk
(Brigham & Women’s Hospital and Harvard Medical School,
Boston, USA) for protein-binding microarrays (PBMs). Scot
Wolfe (University of Massachusetts Medical School,
Worcester, USA) reported new binding profiles for 84
homeodomain transcription factors for Drosophila
melanogaster through a bacterial one-hybrid system, while
Gong-Hong Wei (University of Helsinki, Finland) described
binding profiles for all 27 human and 26 mouse ETS family
members using a microwell-based high-throughput assay
and PBMs, and Christian Grove (University of Massa-
chusetts Medical School, Worcester, USA) reported profiles
for most of the basic helix-loop-helix (bHLH) dimers in
Caenorhabditis elegans using a novel version of assay by
PBMs. Timothy Hughes (University of Toronto, Canada)
described profiles for 300 human and mouse transcription
factors across 23 structural classes, including 168 profiles (of
175 total) for homeodomain transcription factors using PBMs.
All these profiles are highly conserved across species and can
be ported between orthologous transcription factors when
the DNA-contacting amino acids are conserved. This implies
that a full compendium of transcripton factor binding
specificities across all animals can be accomplished in the
near future, with about one third being finished and released
by these groups very soon. A question that remains is
precisely how other contributors to specificity, such as
transcription factor cooperativity, cell-type specific expres-
sion, variant or ‘weak’ recognition sites, and chromatin state
together distinguish between correct target sites of related
transcription factors that have virtually identical position
weight matrices (PWMs).
While the relationship between transcription factors and
their binding profiles is well conserved, independent data
from various speakers showed yet again that the locations of
bona fide regulatory elements are not always conserved in
an alignment between orthologous regions. This plasticity of
transcription factor recognition sites between functionally
conserved regulatory regions is still posing a challenge for
their computational prediction. Pouya Kheradpour (Massa-
chusetts Institute of Technology, Cambridge, USA)
presented a pragmatic solution by allowing for movement of
a predicted site in an alignment, which for many motifs
resulted in increased recovery of conserved sites (sensitivity)
at a given specificity. Furthermore, many nonconserved sites
are located in transposable elements that are generally not
under selection and are usually masked before sequence
analysis. For example, Guillaume Bourque (Genome Insti-
tute of Singapore, Singapore) found that 43% of non-
conserved p53-binding sites are repeat-associated. Ting
Wang (University of California, Santa Cruz, USA) identified
a similar proportion of p53-binding sites in human endo-
genous retrovirus long terminal repeats, and Stamatoyanno-
poulos noted that around 10% of his DHSs map to trans-
posable elements. Mobile elements thus provide an additional
substrate for evolution of species-specific gene regulation.
W Wh ha at t’ ’s s   n ne ex xt t   i in n   t tr ra an ns sc cr ri ip pt ti io on na al l   r re eg gu ul la at ti io on n? ?
The key challenge will be to combine the two topics
highlighted in this report, namely determination of the
specific binding sites for multiple transcription factors and the
genome-scale characterization of chromatin states, and to link
these with spatial and temporal differences in gene
expression. Advances in measuring cell-type specific gene
expression were shown by Bob Waterston (University of
Washington, St Louis, USA), who is using automated image-
processing tools to analyze three-dimensional movies of
fluorescent-marker tagged transcription factors in C. elegans
embryos. Comparing massive numbers of images, they can
make direct quantitative comparisons of expression patterns
of different transcription factors “cell-by-cell, minute-by-
minute”. On the same topic, Philip Benfey (Duke University,
Durham, USA) has leveraged a compendium of gene-
expression data at cell-type specific resolution for an entire
organ. His group performed microarray experiments on
diverse cell lineages across the radial and longitudinal axes
of the Arabidopsis root. A complementary set of
experiments on six different cell types showed that specific
cell types respond uniquely to high-salt or low-iron stress
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Robert Kingston (Harvard Medical School, Boston, USA) is
developing technologies for locus-specific chromatin
isolation to get the complete list of players that bind in vivo
to a regulatory locus. He presented a convincing proof of
principle by isolating 95% of known telomere interactors
and identifying new biologically relevant ones. A more
classical way of determining the input of multiple
transcription factors to a specific locus is by genetic screens.
Results of a high-throughput assay were presented by Pinay
Kainth (University of Toronto, Canada), who tested the
input contributions of all nonessential yeast transcription
factors and their potential regulators on 27 cell-cycle-
specific promoters using quantitative fluorescence
measurements. Although genetic perturbations that alter a
promoter’s output are not limited to the transcription factors
that physically bind to the promoter, such data can
approximate direct interactions, especially when combined
with PWM-based motif predictions.
Once the transcription-factor-specific regulatory sites,
chromatin accessibility, and long-range interactions are
determined for a given cell state, one must still determine
the  cis-regulatory logic and the rate of transcription
initiation that it produces. This is still a difficult problem
addressed by only few groups, including that of Jason Gertz
(Washington University School of Medicine, St Louis, USA),
who reported the use of libraries of synthetic regulatory
regions to examine putative roles of combinations of cis-
elements even before they have been discovered in real
enhancers. This approach provides a possible solution to the
sparse sampling of sets of in vivo validated regulatory
regions that produce a similar output.
This high-quality meeting of regulatory biology researchers
indicates that we are taking important steps toward the
construction of a powerful toolkit to identify and model in
vivo regulatory interactions and networks. The strong proofs
of principle demonstrated at this meeting, together with
increased access to massively parallel sequencing platforms,
anticipate an era in which systems geneticists will
collaborate to perform gene-regulation experiments in
unprecedented detail and scale to characterize their pet
‘regulome’, and niche biologists will apply these technologies
to address specific hypotheses about development, health
and disease.
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